Rasagiline: all 50 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Phase 3 Study With P2B001 in Subjects With Early Parkinson'sCompletedNCT03329508Phase 3Results posted
• Image Parkinson's Disease Progression StudyCompletedNCT02789020Phase 2Results posted
• Rasagiline Rescue in Alzheimer's Disease Clinical TrialCompletedNCT02359552Phase 2Results posted
• A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337764Phase 3Results posted
• A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease ParticipantsCompletedNCT02337751Phase 3Results posted
• A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337738Phase 2/3Results posted
• A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease PatientsCompletedNCT02337725Phase 3Results posted
• Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01786603Phase 2Results posted
• Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's DiseaseCompletedNCT01723228Phase 4Results posted
• Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in ChinaCompletedNCT01556165Phase 3Results posted
• Effect of Rasagiline on BIA 9-1067 PharmacokineticsCompletedNCT01532141Phase 1Results posted
• Effect of BIA 9-1067 on Rasagiline PharmacokineticsCompletedNCT01532128Phase 1Results posted
• Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in ChinaCompletedNCT01479530Phase 3Results posted
• Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in KoreaCompletedNCT01268891Phase 3Results posted
• Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01232738Phase 2Results posted
• Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's DiseaseCompletedNCT01168596Phase 4Results posted
• Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseCompletedNCT01049984Phase 4Results posted
• Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)CompletedNCT00977665Phase 2Results posted
• Rasagiline in the Treatment of Persistent Negative Symptoms of SchizophreniaCompletedNCT00492336Phase 4Results posted
• A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's DiseaseCompletedNCT00256204Phase 3Results posted
• Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized PosturographyWithdrawnNCT07077187Phase 4
• Efficacy and Safety of Rasagiline in Prodromal Parkinson's DiseaseWithdrawnNCT05611372Phase 2/3
• Ambulosono Rasagiline Musical Walking StudyStatus unknownNCT02207387Not applicable
• Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal DetachmentTerminatedNCT02068625Phase 4
• A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of RasagilineCompletedNCT01879748Phase 1
• Study of Rasagiline in Patients With Amyotrophic Lateral SclerosisCompletedNCT01879241Phase 2
• Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center StudyStatus unknownNCT01765257Phase 4
• Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor FluctuationsCompletedNCT01736891Phase 3
• Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and WomenCompletedNCT01652313Phase 1
• A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic TherapyCompletedNCT01497652Phase 4
• Effects of Rasagiline on Sleep Disturbances in Parkinson's DiseaseCompletedNCT01442610Phase 4
• Emotion, Mood and Executive Function in Parkinson's Disease (PD)Status unknownNCT01385735Phase 4
• The Effect of Rasagiline on Cognition in Parkinson's DiseaseCompletedNCT01382342Phase 4
• Safety and Efficacy of Rasagiline in Restless Legs SyndromeTerminatedNCT01192503Phase 2/3
• Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear PalsyTerminatedNCT01187888Phase 3
• Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's DiseaseTerminatedNCT01178047Phase 4
• Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOnCompletedNCT01055379Phase 4
• Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's DiseaseTerminatedNCT01048229Phase 4
• A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's PatientsStatus unknownNCT01007630Phase 4
• Olfaction in Patients With Parkinson's Disease Following Treatment With RasagilineCompletedNCT00902941Phase 4
• Rasagiline and Apathy in Parkinson's DiseaseCompletedNCT00755027Phase 4
• The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's DiseaseStatus unknownNCT00696215Phase 4
• A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
• Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.CompletedNCT00203177Phase 3
• Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCompletedNCT00203164Phase 3
• Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCompletedNCT00203138Phase 3
• A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.CompletedNCT00203125Phase 3
• Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNCT00203060Phase 3
• Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCompletedNCT00203034Phase 3
• Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00104273Phase 2

← Rasagiline overview